Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
13F holders, Q4 2023
Institutional positions in Adma Biologics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 184
- −4 vs. Q3 2023
- Shares held
- 169.2M
- −1.99M (−1.2%) vs. Q3 2023
- Total value
- $764.6M
- +$151.9M (+24.8%) vs. Q3 2023
- New holders
- 21
- 70 more added
- Sold out
- 25
- 59 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 322 | $1.70B |
| Q1 2026 | 358 | $1.91B |
| Q4 2025 | 357 | $4.02B |
| Q3 2025 | 366 | $3.28B |
| Q2 2025 | 369 | $3.84B |
| Q1 2025 | 347 | $4.07B |
| Q4 2024 | 321 | $3.50B |
| Q3 2024 | 306 | $4.16B |
| Q2 2024 | 253 | $2.03B |
| Q1 2024 | 214 | $1.16B |
| Q4 2023 | 184 | $764.6M |
| Q3 2023 | 188 | $612.7M |
| Q2 2023 | 179 | $610.6M |
| Q1 2023 | 163 | $547.2M |
| Q4 2022 | 160 | $592.2M |
| Q3 2022 | 130 | $315.4M |
| Q2 2022 | 113 | $236.0M |
| Q1 2022 | 105 | $189.9M |
| Q4 2021 | 88 | $137.1M |
| Q3 2021 | 72 | $47.3M |
| Q2 2021 | 90 | $68.6M |
| Q1 2021 | 104 | $85.4M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Adma Biologics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −11,152−100.0% | Sold out |
| Orion Portfolio Solutions, LLC | 0 | $0 | 0.00% | −11,152−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −10,571−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1,150−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −867−100.0% | Sold out |
| WR Wealth Planners, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Aspire Private Capital, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |